Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma

Journal of Neuro-Oncology

Volumn 31, Issue 1-2, 1997, Pages 153-158

  Mastrangelo, Renato ^a   Tornesello, Assunta ^a   Lasorella, Anna ^a   Iavarone, Antonio ^a   Mastrangelo, Stefano ^a   Riccardi, Riccardo ^a   Diociaiuti, Luca ^a   Rufini, Vittoria ^a   Pession, Andrea ^b   Troncone, Luigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

131 I metaiodobenzylguanidine; Cisplatin; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CISPLATIN;

ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CHILD; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROBLASTOMA; NEUTROPENIA; PRESCHOOL CHILD; SCHOOL CHILD; THROMBOCYTOPENIA;

3-IODOBENZYLGUANIDINE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODOBENZENES; MALE; NEOPLASM STAGING; NEUROBLASTOMA; RADIONUCLIDE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 8044242349     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005770405844     Document Type: Article

References (12)

1. Heppner GH: Tumor heterogeneity. Cancer Res 44: 2259-2265, 1984
2. Woodruff MFA: Cellular heterogenity in tumours. Br J Cancer 47: 589-594, 1983
3. Matthay KK: An overview on the treatment of neuroblastoma. J Nucl Biol Med 35: 179-182, 1991
4. Troncone L, Riccardi R, Montemaggi P, Rufini V, Lasorella A, Mastrangelo R: Treatment of neuroblastoma with 131-I-Metaiodobenzylguanidine. Med Pediatr Oncol 15: 220-223, 1987
5. Mastrangelo R: The treatment of neuroblastoma with 131-I-MIBG [editorial]. Med Pediatr Oncol 15: 157-158, 1987
6. Mastrangelo R, Troncone L, Lasorella A, Riccardi R, Montemaggi P, Rufini V: 131-I-Metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis. Am J Ped Hematol Oncol 11: 28-31, 1989
7. Mastrangelo R, Lasorella A, Iavarone A, Rufini V, Troncone L, Danza F, Riccardi R: Critical observation on neuroblastoma treatment with 131-I- metaiodobenzylguanidine at diagnosis. Med Pediatr Oncol 21: 411-415, 1993
8. Mastrangelo R, Tornesello A, Riccardi R, Lasorella A, Mastrangelo S, Mancini A, Rufini V, Troncone L: A new approach in the treatment of stage IV neuroblastoma using a combination on 131-I-Metaiodobenzylguanidine (MIBG) and cisplatin. Eur J Cancer 4: 606-611, 1995
9. Dewit L: Combined treatment of radioation and cis-diamminedichloroplatinum (II): a review of experimental and clinical data. Int J Rad Oncol Biol Phys 13: 403-426, 1987
10. De Kraker J, Hoefnagel CA, Caron H, Voute PA, Tiel van Buul MMC, Valdes Olmos R: Targeted radiotherapy with iodine-131-metaiodobenzylguanidine (MIBG) as first line treatment of neuroblastoma advanced disease patients. SIOP XXVI Meeting, Med Pediatr Oncol 23: 179, 1994
11. Reed E, Kohn KW: Platinum analogues. In: Chabner BA, Collins JM (eds) Cancer Chemotherapy. Principles & Practice. J.B.Lippincott, Philadelphia, 1990, pp 465-490
12. Steel GG: The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiot Oncol 11: 31-53, 1988